Advertisement
Screener

NEURAXIS, INC. (NRXS) Capital Expenditure, Discontinued Operations

NEURAXIS, INC. Capital Expenditure, Discontinued Operations

NEURAXIS, INC. (NRXS) reported Capital Expenditure, Discontinued Operations of $106.30 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Notes

us-gaap:CapitalExpenditureDiscontinuedOperations · last filed 2026-08-11

  • NEURAXIS, INC. capital expenditure, discontinued operations for the quarter ending 2026-06-30 was $106.30K, a 1358.60% increase year-over-year.
  • NEURAXIS, INC. capital expenditure, discontinued operations for the quarter ending 2025-06-30 was $7.29K.
Period endCapital Expenditure, Discontinued Operations 3 monthCapital Expenditure, Discontinued Operations 6 month
2026-06-30$106.30K
10-Q · filed 2026-08-11
$106.30K
10-Q · filed 2026-08-11
2025-06-30$7.29K
10-Q · filed 2026-08-11
$25.29K
10-Q · filed 2026-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
electroCore, Inc. (ECOR)United States$0.102B
Streamex Corp. (STEX)United States$0.089B-0.19
Vivani Medical, Inc. (VANI)United States$0.111B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B